Skip to main content Accessibility help
×
×
Home

Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic

  • P. Kriz (a1), J. Vlckova (a2) and M. Bobak (a3)

Summary

Vaccination against Neisseria meningitidis is not part of routine immunization schemes in any country; instead, targeted vaccination of groups at the highest risk is recommended during outbreaks and epidemics. After a long period of sporadic occurrence of meningococcal invasive disease, a new clone of Neisseria meningitidis C: 2a: P1.2, ET-15/37, occurred in the Czech Republic, and caused local outbreaks in two neighbouring districts, Olomouc and Bruntal, in spring 1993. In Olomouc, a mass campaign was conducted during which 6191 students were vaccinated (5·6 % of the total population of this locality and 96% of all students in the age group 15–19) within 2 weeks in June 1993. In Bruntal district, no such campaign was organized. In Olomouc, the incidence of invasive disease caused by Neisseria meningitidis C in the age group 10–24 decreased from 57 to 0 per 100000 (P < 0·001) during the post-vaccination period (July 1993–August 1994), but no such decrease was observed in Bruntal. Although other factors can affect the frequency of disease, these results support the current recommendations of targeted vaccination in outbreaks of meningococcal disease.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Targeted vaccination with meningococcal polysaccharide vaccine in one district of the Czech Republic
      Available formats
      ×

Copyright

References

Hide All
1.Bohr, V, Hansen, BO, Kjersem, H et al. , Sequelae from bacterial meningitis and their relation to the clinical condition during acute illness, based on 667 questionnaire returns. J Infect 1983; 7: 102–10.
2.Greenwood, BM, Bradley, AK, Smith, AW, Wall, RA. Mortality from meningococcal disease during an epidemic in the Gambia, West Africa. Trans R Soc Trop Med Hyg 1987; 81: 536–8.
3.Halstensen, A, Pedersen, SHJ, Haneberg, B et al. , Case fatality of meningococcal disease in western Norway. Scand J Infect Bis 1987; 19: 3542.
4.Cartwright, KAV, Stuart, M, Noah, ND. An outbreak of meningococcal disease in Gloucestershire. Lancet 1986; ii: 558–61.
5.Rønne, T, Lind, I, Buhl, LH, Poolman, JT, Zoffmann, H. Recurrent localized outbreaks of group C meningococcal disease and selective vaccination programmes. Anton Leeuwenhoek J Microbiol Serol 1986; 52: 221–2.
6.Ashton, FE, Ryan, A, Borczyk, AL, Caugant, DA, Mancino, L, Huang, D. Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol 1991; 29: 2489–93.
7.Whalen, CM, Hockin, JC, Ryan, A, Ashton, F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA 1995; 273: 390–4.
8.Jackson, LA, Schuchat, A, Reevers, MW, Wenger, JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 1995; 273: 383–9.
9.Branham, SE. Serological relationship among meningococci. Bacterial Rev 1953; 17: 175–88.
10.Branham, SE. Reference strains for the serologie groups of meningococcus. Int Bull Bact Nomencl Taxon 1958; 8: 115.
11.Slaterus, KW. Serological typing of meningococci by means of micro-precipitation: Anton Leeuwenhoek J Microbiol Serol 1961; 27: 304–15.
12.Evans, JR, Artenstein, MS, Hunter, DH. Prevalence of meningococcal serogroups and description of three new groups. Am J Epidemiol 1968; 87: 643–6.
13.Ding, SQ, Ye, RB, Zhang, HC. Three new serogroups of Neisseria meningitidis. J Biol Stand 1981; 9: 307–15.
14.Ashton, FE, Ryan, A, Diena, B, Jennings, HJ. A new serogroup L of Neisseria meningitidis. J Clin Microbiol 1983; 17: 722–7.
15.Grahlow, WD, Kuzemenska, P. Meningitis in a child due to Neisseria meningitidis group K. Infection 1989; 17: 309–10.
16.Frasch, CE, Zollinger, WD, Poolman, JT. Serotype antigens of Neisseria meningitidis and proposed scheme for designation of serotypes. Rev Infect Dis 1985; 7: 504–10.
17.Abdillahi, H, Poolman, JT. Definition of meningococcal class I OMP subtype antigens by monoclonal antibodies. FEMS Microbiol Immunol 1988; 47: 139–44.
18.Ceesay, SJ, Allen, SJ, Menon, A et al. , Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis 1993; 167: 1212–6.
19.Käyhty, H, Karanko, V, Peltola, H, Sarna, S, Mäkela, PH. Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children. J Infect Dis 1980; 142: 861–8.
20.Gold, R, Lepow, ML, Goldschneider, I, Gotschlich, EC. Immune response of human infants to polysaccharide vaccines of groups A and C Neisseria meningitidis. J Infect Dis 1977; 136: 831–5.
21.Lepow, ML, Goldschneider, I, Gold, R, Randolph, M, Gotschlich, EC. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics 1977; 60: 673–80.
22.Peltola, H, Mäkela, PH, Käyhty, H et al. , Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. New Engl J Med 1977; 297: 686–91.
23.Reingold, AL, Broome, CV, Hightower, AW et al. , Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 1985; ii: 114–18.
24.WHO Study Group. Cerebrospinal meningitis control. WHO Tech Rep 1976; Ser 588: 822.
25.Public Health Advisory Committee on Immunization Practices: Meningococcal polysaccharide vaccines. MMWR 1975; 24: 381–2.
26.Mäkela, PH, Käyhty, H, Weckstrom, P et al. , Effects of group A meningococcal vaccine in army recruits in Finland. Lancet 1975; ii: 883–6.
27.Stroffolini, T. Vaccination campaign against meningococcal disease in army recruits in Italy. Epidemiol Infect 1990; 105: 579–83.
28.Greenwood, BM, Wali, SS. Control of meningococcal infection in the African meningitis belt by selective vaccination. Lancet 1980; i: 729–32.
29.Greenwood, BM, Smith, AW, Hassan-King, M et al. , Theefficacyof meningococcal polysaccharide vaccine in preventing group A meningococcal disease in the Gambia, West Africa. Trans R Soc Trop Med Hyg 1986; 80: 106–7.
30.Mäkela, PH, Peltola, H, Käyhty, H et al. , Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis 1977; 136 (suppl.): S43–S50.
31.Moore, PS, Toole, MJ, Nieburg, P, Waldman, RJ, Broome, CV. Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bull WHO 1990; 68: 587–96.
32.Peltola, H. Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis 1978; 10: 41–4.
33.Rønne, T, Berthelsen, L, Buhl, LH, Lind, I. Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease. Scand J Infect Dis 1993; 25: 331–9.
34.Kuzemenska, P, Kriz, B. Epidemiology of meningococcal disease in Central and Eastern Europe. In Vedros, NA, ed. Evolution of meningococcal disease, vol I. Boca Raton, Florida: CRC Press, Inc, 1987: 103–37.
35.Kriz-Kuzemenska, P, Benes, C, Dlhy, J et al. , Increased incidence of invasive meningococcal disease in some regions in the Czech Republic caused by meningococcus C:2a:P1.2. Cs Epidemiol 1993; 42: 165–71.
36.Kriz, P, Musilek, M, Lebedova, V. New epidemiological situation in the Czech Republic caused by meningococcus C:2a:Pl.2(P1.5). Epidemiol Microbiol Immunol 1994; 43: 183–7.
37.Roznovsky, L, Matuska, J, Kriz-Kuzemenska, P. Unusual incidence of serious meningococcal diseases in some north Moravian districts in the first half of 1993. Prakt lek 1994; 74: 101–4.
38.Selander, RK, Caugant, DA, Ochman, H, Musser, JM, Gilmour, MN, Whitam, TS. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol 1986; 51: 873–84.
39.Caugant, DA, Frøholm, LO, Bovre, K et al. , Intercontinental spread of a genetically distinctive complex of clones of Neisseria meningitidis causing epidemic disease. Proc Natl Acad Sci 1986; 83: 4927–31.
40.Kirkwood, BR. Essentials of medical statistics. Oxford: Blackwell Scientific Publications, 1988.
41. EGRET users manual. Seattle: Statistics and Epidemiology Research Corporation, 1988.
42.Cuevas, LE, Hart, CA. Chemoprophylaxis of bacterial meningitis. J Antimicrob Chemother 1993; 31 Suppl B: 7991.
43.Lennon, D, Gellin, B, Hood, D, Voss, L, Heffernan, H, Thakur, S. Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand. Pediatr Infect Dis J 1992; 11: 617–23.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed